Company / Free Cash Flow per Share
GYRE THERAPEUTICS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.00
FY2025
5-year range
-$3.83 / $0.09
FY2021-FY2025
Trend
+97.3%
vs FY2024
Sector context
#66 of 192
Health Care
What the data says
At $-0.00, GYRE THERAPEUTICS, INC.'s free cash flow per share ranks #66 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-24.31 in FY2016 to $0.09 in FY2023.
Based on SEC 10-K filings.
-0.00 in FY2025.
Declined from $0.09 to $-0.00 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#66 of 192 in Health CareTop 34% of 192This company -$0.00 Sector average $3.32
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 97.3% year-over-year.
- Ranks #66 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.00 | +97.3% |
| FY2024 | -$0.08 | -186.9% |
| FY2023 | $0.09 | +19.0% |
| FY2022 | $0.08 | +102.0% |
| FY2021 | -$3.83 | - |
| FY2020 | - | - |
| FY2019 | -$3.65 | -11.3% |
| FY2018 | -$3.28 | +43.7% |
| FY2017 | -$5.83 | +76.0% |
| FY2016 | -$24.31 | +63.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026